Diagnostics

Fortis Healthcare Q3 FY23; Revenue Increased By 6% Year On Year

● Feb 10, 2023

Fortis Healthcare Limited (NSE: FORTIS) reported a Revenue from Operations of ₹1,559.88 Crores, an increased of 6% growth from the...

● Feb 9, 2023

Net profit of Thyrocare Technologies declined by 43.47% to INR 13 crore in the quarter ended December 2022 as against...

● Feb 3, 2023

Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q3 FY23 Earnings Concall Q&A Highlights: [00:12:28] Dheeresh Pathak from WhiteOak asked...

● Dec 30, 2022

“The second quarter saw a healthy improvement in the demand for Non-COVID business across all segments. The Company managed to...

● Nov 10, 2022

Krsnaa Diagnostics Ltd (NSE:KRSNAA) Q2 FY23 Earnings Concall dated Nov. 10, 2022 Corporate Participants: Yash Prithviraj Mutha C.A. — Whole-Time...

● Nov 10, 2022

Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q2 FY23 Earnings Concall Q&A Highlights: [00:16:43] Rahul Agarwal with Incred Capital...

● Aug 3, 2022

Dr. Lal PathLabs Ltd (NSE: LALPATHLAB), a leading provider of diagnostic and related healthcare services, has reported lower revenues and...

● Aug 3, 2022

Stock Data Ticker: LALPATHLAB Exchange : NSE BSE: 539524 Industry: Diagnostic Price Performance Last 7 days 8.70% YTD -38.28% Last...

● Aug 3, 2022

Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q1 FY23 Earnings Concall Management Update: LALPATHLAB said it clocked the highest...

● Jul 1, 2022

Overview Dr Lal PathLabs Limited is an Indian diagnostic company. It was incorporated in 1949. The headquarters is situated in Delhi,...